Senestech, Inc. income statement
In fiscal 2025, Senestech, Inc. reported revenue of $2.2m, up 19.6% on the year before, operating income of −$6.5m (a -292.9% margin) and net income of −$6.4m, or −$1.95 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 2 | 2 |
| Cost of revenue | — | — | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
| Gross profit | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 |
| Research and development | 7 | 3 | 3 | 2 | 2 | 1 | 2 | 2 | 1 | 2 | 2 | 2 |
| General and administrative | 9 | 8 | 9 | 10 | 8 | 6 | 7 | 8 | 7 | 6 | 6 | 7 |
| Operating income | −16 | −11 | −12 | −12 | −10 | −8 | −9 | −10 | −8 | −6 | −7 | −7 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income tax | — | — | — | — | — | — | — | — | — | 0 | 0 | — |
| Net income | −18 | −11 | −12 | −12 | −10 | −8 | −8 | −10 | −8 | −6 | −6 | −7 |
| Diluted EPS | −$2260.80 | −$3.42 | −$2.24 | −$302.88 | −$0.77 | −$66.72 | −$17.72 | −$14.81 | −$11.51 | −$8.86 | −$1.95 | — |
| Diluted shares (average) | — | — | — | — | — | — | — | — | — | — | 3m | — |
| EBITDA | −15 | −10 | −12 | −11 | −10 | −8 | −9 | −9 | −8 | −6 | −6 | −7 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 482 | 501 | 485 | 625 | 690 | 421 | 493 | 770 |
| Cost of revenue | 167 | 196 | 172 | 216 | 257 | 188 | 155 | 203 |
| Gross profit | 315 | 305 | 313 | 409 | 433 | 233 | 338 | 567 |
| Research and development | 451 | 424 | 418 | 427 | 400 | 453 | 422 | 377 |
| General and administrative | 1,411 | 1,138 | 1,558 | 1,596 | 1,380 | 1,661 | 2,035 | 2,052 |
| Operating income | −1,547 | −1,257 | −1,663 | −1,614 | −1,347 | −1,881 | −2,119 | −1,862 |
| Interest expense | 6 | 7 | 5 | 6 | 6 | 5 | 4 | 5 |
| Net income | −1,513 | −1,255 | −1,665 | −1,616 | −1,298 | −1,804 | −2,063 | −1,832 |
| Diluted EPS | −$2.07 | −$0.46 | −$1.28 | −$0.87 | −$0.28 | −$0.20 | −$0.39 | −$0.35 |
| EBITDA | −1,505 | −1,216 | −1,624 | −1,579 | −1,318 | −1,849 | −2,088 | −1,831 |
Compare with peers
- Park Ha Biological Technology Co., Ltd. income statement
- Zone Frontier Inc. income statement
- Citrotech Inc. income statement
- Research Frontiers Inc income statement
- J-star Holding Co., Ltd. income statement
Head to head: BYAH vs SNESSNES vs ZONECITR vs SNESREFR vs SNES
More: Specialty Chemicals stocks compared, Materials sector, rankings of US companies